✦ LIBER ✦

Characterisation of a novel high-purity, double virus inactivated von Willebrand Factor and Factor VIII concentrate (Wilate®)

✍ Scribed by M. Stadler; G. Gruber; C. Kannicht; L. Biesert; K.U. Radomski; H. Suhartono; K. Pock; A. Neisser-Svae; J. Weinberger; J. Römisch; T.-E. Svae

Book ID: 113491563
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 622 KB
Volume: 34
Category: Article
ISSN: 1045-1056
DOI: 10.1016/j.biologicals.2005.11.010

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of a high purity, do

Efficacy and safety of a high purity, double virus inactivated factor VIII/von Willebrand factor concentrate (Biostate®) in patients with von Willebrand disorder requiring invasive or surgical procedures

✍ J. SHORTT; S. DUNKLEY; K. RICKARD; R. BAKER; A. STREET 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

Treatment and prevention of acute bleedi

Treatment and prevention of acute bleedings in von Willebrand disease – efficacy and safety of Wilate®, a new generation von Willebrand factor/factor VIII concentrate

✍ E. BERNTORP; J. WINDYGA; THE EUROPEAN WILATE STUDY GROUP 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Use of a High-Purity Factor VIII Concent

Use of a High-Purity Factor VIII Concentrate (Hemate P) in von Willebrand's Disease

✍ Erik Berntorp; Inga Marie Nilsson 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 566 KB

Experience with Optivate®, a new high pu

Experience with Optivate®, a new high purity concentrate of factor VIII with von Willebrand factor, in patients undergoing surgery

✍ C. R. M. HAY; A. HELLMANN; A. DMOSZYNSKA; T. BAGLIN; D. O’SHAUNESSEY; M. MAKRIS; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 187 KB

Pharmacokinetics of Optivate®, a high-pu

Pharmacokinetics of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in patients with severe haemophilia A

✍ A. DMOSZYNSKA; A. HELLMANN; T. BAGLIN; D. O’SHAUGNESSY; J. TRELINSKI; K. KULICZK 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB

Clinical assessment of Optivate®, a high

Clinical assessment of Optivate®, a high-purity concentrate of factor VIII with von Willebrand factor, in the management of patients with haemophilia A

✍ A. DMOSZYNSKA; K. KULICZKOWSKI; A. HELLMANN; J. TRELINSKI; J. KLOCZKO; T. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB